After 17 years at Genentech, Ira Mellman is joining the Parker Institute for Cancer Immunotherapy as president of research.

Under the 11-page 'roadmap' outlined Thursday, the goal is for alternative methods to become 'the exception rather than the ...

Bristol Myers Squibb’s combined immunotherapies Opdivo and Yervoy won approval this week as a first-line treatment for ...

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

CDMOs fear that FDA site inspections might slow down due to the mass staffing cuts at the federal health agencies.

Trump signals imminent pharma tariffs, with experts including Mollie Sitkowski of Faegre Drinker suggesting 25% levy possible ...

Argenx's Vyvgart Hytrulo gets FDA approval for self-injection syringe, Opthea cuts 65% staff after trial failures, Protagonist reports psoriasis success, Pfizer cuts jobs, Keros reviews options ...

VC execs write to Sen. Cassidy about FDA staffing concerns, citing delays & uncertainties due to loss of experienced staff & ...

RFK Jr.'s first TV interview as HHS head reveals vaccine skepticism, support for measles shots, Novavax concerns, HHS cuts, ...

Researchers at AAN meeting discuss myasthenia gravis advances as J&J reports long-term data for nipocalimab, while argenx's ...

With US tariffs on pharmaceuticals likely to come 'very soon,' another of the world's largest drugmakers is announcing plans ...

A biotech incubated by RA Capital has secured a $57.5 million Series B to begin a mid-stage trial for its cardio drug this ...